Advertisement
Singapore markets open in 8 hours 46 minutes
  • Straits Times Index

    3,303.19
    +10.26 (+0.31%)
     
  • S&P 500

    5,155.72
    +27.93 (+0.54%)
     
  • Dow

    38,709.32
    +33.64 (+0.09%)
     
  • Nasdaq

    16,259.89
    +103.56 (+0.64%)
     
  • Bitcoin USD

    63,541.36
    -919.25 (-1.43%)
     
  • CMC Crypto 200

    1,371.39
    +58.76 (+4.48%)
     
  • FTSE 100

    8,213.49
    +41.34 (+0.51%)
     
  • Gold

    2,334.70
    +26.10 (+1.13%)
     
  • Crude Oil

    78.61
    +0.50 (+0.64%)
     
  • 10-Yr Bond

    4.4980
    -0.0020 (-0.04%)
     
  • Nikkei

    38,236.07
    -38.03 (-0.10%)
     
  • Hang Seng

    18,578.30
    +102.38 (+0.55%)
     
  • FTSE Bursa Malaysia

    1,597.39
    +7.80 (+0.49%)
     
  • Jakarta Composite Index

    7,135.89
    +1.17 (+0.02%)
     
  • PSE Index

    6,652.49
    +36.94 (+0.56%)
     

Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 million

The logo for Labcorp is displayed on a screen on the floor of the NYSE in New York

(Reuters) - Laboratory service provider Labcorp said on Wednesday it will acquire Softbank-backed Invitae Corp's assets auctioned through a voluntary bankruptcy protection process, a few months after the genetic test maker filed for bankruptcy.

Labcorp will acquire all of the bankrupt firm's assets on a going concern basis for $239 million in cash consideration and other non-cash consideration, the companies said in separate statements.

In February, Invitae filed for voluntary Chapter 11 protection in a U.S. bankruptcy court and said that it intended to pursue a sale process.

Invitae's estimated assets were in the $500 million - $1 billion range, while its liabilities were in the $1 billion - $10 billion range, according to the bankruptcy filing.

(Reporting by Chandni Shah in Bengaluru; Editing by Mrigank Dhaniwala)